Harmony Biosciences Holdings, Inc. HRMY Business Segments — D&A

Similar metrics at other companies

KMBNA — D&A

$144M+38.5%

RYTMD&A

$252K-34.2%

FNFTitle — D&A

$35M-2.8%

GLXYDigital Assets — D&A

$3.16M-11.0%

OPLNFinance — D&A

$3.2M+6.7%

EXPOEnvironmental And Health — D&A

$45K-4.3%

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s business segments — D&A?

Harmony Biosciences Holdings, Inc. (HRMY) reported business segments — D&A of $5.97M in Q1 2026.

How has Harmony Biosciences Holdings, Inc.'s business segments — D&A changed year-over-year?

Harmony Biosciences Holdings, Inc.'s business segments — D&A decreased by 0.0% year-over-year, from $5.97M to $5.97M.

What is the long-term trend for Harmony Biosciences Holdings, Inc.'s business segments — D&A?

Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s business segments — D&A has grown at a 2.7% compound annual growth rate (CAGR), from $23.39M to $25.34M.

What does business segments — D&A mean?

This represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the segment. It is essential for understanding the capital intensity and asset base required to support the company's commercial operations.